$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
What are the side effects of alectinib in treating lung cancer? What are the precautions
2025-10-19 11:44:20
Check Details
What is the function of gefitinib? What are the side effects of long-term use
2025-10-19 11:44:20
Check Details
What are the side effects of topotecan? What is the usage and dosage?
2025-10-19 11:44:20
Check Details
What are the adverse reactions of tipotinib hydrochloride and how to deal with them?
2025-10-19 11:44:20
Check Details
What are the side effects of Osimertinib? Will the side effects of Osimertinib always occur?
2025-10-19 11:44:20
Check Details
What are the side effects of cabozantinib and how to reduce the side effects?
2025-10-19 11:44:20
Check Details
Can cabozantinib be stopped if side effects occur? What are the precautions?
2025-10-19 11:44:20
Check Details
What are the common adverse reactions of nivolumab and what should we pay attention to?
2025-10-19 11:44:20
Check Details
What are the side effects of gefitinib and what are the contraindications?
2025-10-19 11:44:20
Check Details
How to deal with severe rashes after taking gefitinib, and how long does it take for the side effects to disappear?
2025-10-19 11:44:20
Check Details
What are the side effects of erlotinib and how to deal with them?
2025-10-19 11:44:20
Check Details
What are the side effects of afatinib, and will they last forever?
2025-10-19 11:44:20
Check Details
1
2
...
4100
4101
4102
4103
4104
4105
4106
...
4154
4155
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Garsorasib Clinical Updates and KRAS G12C Targeted Therapy Prospects
2
FDA Accelerates Approval of Zongertinib: Precision Medicine Advancement for HER2-Mutated NSCLC
3
Sotorasib (Lumakras®): The First KRAS Inhibitor Revolutionizing Non-Small Cell Lung Cancer Treatment
4
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
5
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
6
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
7
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
8
Adagrasib Medication Management Guide for Special Populations
9
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
10
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
11
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
12
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer